Effect of HLA Compatibility on Engraftment of Bone Marrow Transplants in Patients with Leukemia or Lymphoma

C Anasetti(Fred Hutch Cancer Center), K Doney(University of Washington Medical Center), D. B. Amos(Florida College), E. Mickelson, CD Buckner(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), R. A. Clift(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), P Beatty(Bloodworks Northwest), W Bensinger, F R Appelbaum(City Of Hope National Medical Center)
New England Journal of Medicine
January 26, 1989
10.1056/nejm198901263200401
Cited by 687

Related Papers

Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
|PubMed|1996|645
Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate
|Blood|1999|456
Graft-versus-Host Disease and Survival in Patients with Aplastic Anemia Treated by Marrow Grafts from HLA-Identical Siblings
|New England Journal of Medicine|1983|435
Secondary Cancers after Bone Marrow Transplantation for Leukemia or Aplastic Anemia
|New England Journal of Medicine|1989|421